CN101628131A - Method for preparing ultra-thin porous lamination gradient composite support of tissue engineering - Google Patents

Method for preparing ultra-thin porous lamination gradient composite support of tissue engineering Download PDF

Info

Publication number
CN101628131A
CN101628131A CN200910306024A CN200910306024A CN101628131A CN 101628131 A CN101628131 A CN 101628131A CN 200910306024 A CN200910306024 A CN 200910306024A CN 200910306024 A CN200910306024 A CN 200910306024A CN 101628131 A CN101628131 A CN 101628131A
Authority
CN
China
Prior art keywords
preparation
ultra
tissue engineering
thin porous
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200910306024A
Other languages
Chinese (zh)
Inventor
张胜民
仇志烨
黄浩
周磊
王深琪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huazhong University of Science and Technology
Original Assignee
Huazhong University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huazhong University of Science and Technology filed Critical Huazhong University of Science and Technology
Priority to CN200910306024A priority Critical patent/CN101628131A/en
Publication of CN101628131A publication Critical patent/CN101628131A/en
Pending legal-status Critical Current

Links

Landscapes

  • Prostheses (AREA)

Abstract

本发明公开了一种超薄多孔叠层梯度组织工程复合支架的制备方法,属于生物医学材料领域。该制备方法包括以下步骤:1)根据修复缺损情况,确定待制备支架的材料和结构;2)制备各层支架,等待溶剂挥发,浆料逐渐变干成型;3)将成型物置于通风处,等待残留溶剂完全挥发后脱模;4)取出成型物,进行干燥,即得超薄多孔叠层梯度组织工程复合支架。使用该方法可制备厚度适合于关节骨软骨修复的超薄多孔叠层复合支架,制备的支架力学性能良好,生物相容性好,降解速率可控,能适应成骨细胞和软骨细胞共同培养及特异性生长因子的复合,可同时进行关节软骨组织和软骨/骨组织综合缺损的修复。The invention discloses a preparation method of an ultra-thin porous laminated gradient tissue engineering composite support, which belongs to the field of biomedical materials. The preparation method includes the following steps: 1) determining the material and structure of the stent to be prepared according to the condition of the repair defect; 2) preparing the stent of each layer, waiting for the solvent to evaporate, and the slurry gradually becomes dry and formed; 3) placing the formed object in a ventilated place, Waiting for the residual solvent to completely volatilize before demoulding; 4) Take out the molded product and dry it to obtain an ultra-thin porous laminated gradient tissue engineering composite scaffold. Using this method, an ultra-thin porous laminated composite scaffold with a thickness suitable for articular osteochondral repair can be prepared. The prepared scaffold has good mechanical properties, good biocompatibility, and controllable degradation rate, and can adapt to the co-culture of osteoblasts and chondrocytes. The combination of specific growth factors can simultaneously repair articular cartilage tissue and cartilage/bone tissue comprehensive defects.

Description

A kind of preparation method of ultra-thin porous lamination gradient composite support of tissue engineering
Technical field
The invention belongs to field of biomedical materials, be specifically related to be used for the preparation method of the porous lamination composite support of tissue engineering that the ossa articularia cartilage defect repairs.
Background technology
Articular cartilage defect is very common disease, because articular cartilage special organization structure and biological characteristics, though the known method that many treatment articular cartilage defects are arranged, all these methods all can not reach satisfied repairing effect.The appearance of tissue engineering technique makes the damaged reparation of cartilaginous tissue become possibility.Its ultimate principle is, the cartilaginous tissue cell inoculation that in-vitro separation is cultivated is to the three-dimensional rack with certain space structure and good biocompatibility, be aided with special somatomedin simultaneously, complex with cell-scaffold implants behind the In vitro culture certain hour more then, propagation along with cell, timbering material is constantly degraded, and is replaced by extracellular matrix, forms the tissue with normal function gradually.Wherein, support is one of key element of organizational project.Because the bone cartilage has multiple structure, comprise cartilage layers, calcified cartilage layer, subchondral bone layer and osseous tissue from outside to inside, the cartilage injury may relate to calcified cartilage, subchondral bone even osseous tissue, therefore to select degradation rate controlled and can repair the porous lamination support of multilayer tissue simultaneously as required, this support has multiple structure, and the performance of each layer should be able to adapt to the reparation of respective layer tissue.This support also should have higher porosity, with the growth and the propagation of suitable cell, and the conveying of nutrient substance and metabolic waste.
Report according to pertinent literature, the thickness of outside articular surface cartilage is 1.5~3 millimeters (D.E.T.Shepherd.B.B.Seedhom.Thickness of human articular cartilage in joints of thelower limb.Ann.Rheum.Dis.1999 in the human body knee joint, 58:27-34), because osteochondral defect may relate to subchondral bone even osseous tissue, the thickness that therefore is used to repair ossa articularia cartilage injury's timbering material should be 2~4 millimeters.At present, because technology is limit, the thickness of the compound cartilage tissue engineering rack of porous lamination of development is all much larger than repairing the needed thickness of osteochondral defect both at home and abroad, usually above 6 millimeters, even reach 9 millimeters (S.Ghosh etc., Bi-layered constructs based onpoly (L-lactic acid) and starch for tissue engineering of osteochondral defects, Materials Science and Engineering C, 2008,28:80-86), be used for defect repair and can cause big wound.In the porous lamination compound rest preparation technology of routine, each of support layer quilt prepares respectively, is superimposed and carries out certain bondingly, forms stack trays.In such preparation technology, bond strength is relatively poor between layer and the layer, pore communication is poor, and porous each layer must possess certain thickness to keep its structure, pattern and certain intensity.Report according to pertinent literature, the thickness of porous monolayer compound rest can't be accomplished less than 1.5 millimeters (Anna Tampieri etc., Design of gradedbiomimetic osteochondral composite scaffolds, Biomaterials, 2008,29:3539-3546), therefore, according to above-mentioned conventional preparation technology, the thickness of porous two-layer compound support can't accomplish less than 3 millimeters, and the integral thickness with porous lamination support of structure more than three layers or three layers more can't reach repairs required 2~4 millimeters of ossa articularia cartilage injury.
Summary of the invention
The objective of the invention is the preparation method that provides a kind of ultra-thin porous lamination gradient composite support of tissue engineering for addressing the above problem.Use this method can prepare the ultra-thin porous lamination compound rest that thickness is suitable for the ossa articularia repair of cartilage.
The technical solution adopted in the present invention is:
A kind of preparation method of ultra-thin porous lamination gradient composite support of tissue engineering, this preparation method may further comprise the steps:
1), determines the material and the structure of support to be prepared according to the repair deficiency situation;
2) organic material that will prepare the ground floor support is dissolved in the solvent, solvent for use is an easy volatile solvent, after treating that organic material dissolves fully, add inorganic material again, stir and form uniform mixed slurry, this mixed slurry is poured in the flat mould again, make slurry evenly be tiled in mold bottom, place the environment that helps solvent evaporates then, wait for solvent evaporates, the volatilization time is 0.5~12 hour, the mixed slurry molding that becomes dry gradually;
3) according to step 2) operation, the mixed slurry of preparation second layer support directly is poured on mixed slurry on the ground floor support that has prepared molding, and make the slurry tiling evenly, place the environment that helps solvent evaporates then, wait for the molding that becomes dry gradually of solvent evaporates, slurry;
4), successively prepare the 3rd to N shell support (N 〉=2) according to the operation of step 3);
5) article shaped is placed the ventilation, the demoulding after the wait residual solvent volatilizees fully;
6) take out article shaped, carry out drying, promptly get ultra-thin porous lamination gradient composite support of tissue engineering.
Preferably, described step 2) to step 4), can add porogen, its concrete steps are: with porogen and inorganic material mix homogeneously, add in the solution of organic material again, stir and form uniform mixed slurry.
Preferably, the concrete steps of described adding porogen are: after inorganic material is added the solution of organic material and stirring, add porogen again, stir and form uniform mixed slurry.
Further, described step 2) add porogen to the step 4) after, the article shaped in the step 5) need be soaked with pure water, removes porogen.
Further, in the preparation process of described certain one deck, the amount of solvent for use can be dissolved preparation this layer used organic material fully, and prepares the used inorganic material of this layer and be insoluble to this solvent, but inorganic material must be dispersed in mixed flow mutually in.
Further, to account for the mass percent of each layer support be 0%~60% to described inorganic material.
Preferably, described organic material is artificial synthesizing polymeric material or natural polymeric material, or the mixing of worker's synthesizing polymeric material and natural polymeric material.
More preferably, described artificial-synthetic copolymer's material is a polylactic acid (polylactide, polylactic acid, PLA), polyglycolic acid (poly-Acetic acid, hydroxy-, bimol. cyclic ester, polyglycolic acid, polyglycolic acid, PGA), polylactic acid-glycolic guanidine-acetic acid copolymer (poly (lactic-co-glycolic acid), PLGA), polycaprolactone (polycaprolactone, PCL), polyamide (polyamide, PA), polyvinyl alcohol (polyvinyl alcohol, PVA).
More preferably, described natural polymeric material be fibroin albumen (fibroin), collagen (collagen), chitosan (chitosan), hyaluronic acid (haluronic acid, HA).
Preferably, described inorganic material is a calcium phosphorus series active biomaterial.
More preferably, described calcium phosphorus series active biomaterial is hydroxyapatite (hydroxyapatite, HA), α tricalcium phosphate (α-tricalcium phosphate, α-TCP), β tricalcium phosphate (β-tricalcium phosphate, β-TCP), tetracalcium phosphate and element doping modified calcium phosphor biological material.
Further, described porogen is a solid particle, and particle diameter is 30~500 microns, the solvent that employed porogen uses when being insoluble to this layer of preparation, but water-soluble.
Preferably, described pure water is distilled water, deionized water or reverse osmosis water.
The present invention has the following advantages:
Utilize the present invention can prepare the ultra-thin porous lamination compound rest that thickness is suitable for the ossa articularia repair of cartilage, the support good mechanical properties of preparation, good biocompatibility, degradation rate is controlled, the compound of osteoblast and chondrocyte co-cultivation and specificity growth factor can be adapted to, the comprehensive damaged reparation of articular cartilage tissue and cartilage/bone tissue can be carried out simultaneously.
The specific embodiment
Embodiment 1
Preparation thickness is 1.5 millimeters zinc hydroxyapatite/polylactic acid two-layer compound support.Mould therefor is that an internal diameter is the cylindrical flat glass container of 60mm.Used organic material is Poly-L-lactic acid (PLLA, a molecular weight 50000); (nano-Zn-HA, elongated piece are grown 80~120nm to used inorganic material, and be wide by 20~50nm) in order to contain the zinc nanometer hydroxyapatite; Solvent for use is acetone (C 3H 6O); Used porogen is sodium chloride (NaCl is divided into two kinds of particle diameter 50~200 μ m and particle diameter 200~300 μ m).The stack trays thickness of desire preparation is 1.5mm, and the ground floor of its medium-height trestle (lower floor) thickness is 0.5mm, and the second layer (upper strata) thickness is 1mm.The ground floor composition of support is nano-Zn-HA and PLLA mixture, and the mass ratio of nano-Zn-HA and PLLA is 30: 70; The second layer composition of support is pure PLLA.Preparation is during support, begins preparation from the ground floor of support, prepares the second layer again on ground floor, and promptly mold bottom is the lower floor of support in preparation process, is the upper strata of support on it.
Take by weighing 0.16g PLLA, be dissolved in 1.4ml C 3H 6Among the O, treat that PLLA dissolves the back fully and adds 0.07g nano-Zn-HA, stir and form uniform sizing material, the NaCl that adds 1.8g particle diameter 200~300 μ m again stirs and forms uniform sizing material, and slurry is poured in the mould, and make slurry evenly be laid on mold bottom, left standstill 4 hours, and treated solvent evaporates, form the ground floor of support.
Take by weighing 0.45g PLLA, be dissolved in 2.8ml C 3H 6Among the O, treat that PLLA dissolves the NaCl that the back adds 3.4g particle diameter 50~200 μ m fully, stir to form uniform sizing material, slurry is poured in the mould, and slurry evenly is laid on the support ground floor of shaping, left standstill 4 hours, treat solvent evaporates, form the second layer of support.
Article shaped is placed fume hood, 30 ℃ of volatilization demouldings after 48 hours down.Article shaped is immersed in the deionized water, changed a deionized water, and in the water that soaks usefulness, can not detect chloride ion (Cl in per 6 hours -).With article shaped lyophilization 36 hours, make the porous lamination compound rest again.
After testing, this support average thickness is 1.53 millimeters, and porosity is 86.6%, adheres to specification.Experiment showed, that through external and vivo degradation this scaffold degradation product is nontoxic, can not cause aseptic inflammation, support degradation time in vivo is 20 days, meets the requirement of clinical bone repair of cartilage.Repair through animal and experiment showed, that this support can repair the ossa articularia cartilage defect of dark and calcified cartilage layer well.
Embodiment 2:
Preparation thickness is three layers of compound rest of hydroxyapatite/polylactic acid-hydroxyacetic acid of 3 millimeters.Mould therefor is that an internal diameter is the cylindrical flat glass container of 40mm.Used organic material is polylactic acid-glycolic guanidine-acetic acid (PLGA, molecular weight 100000, LA: GA=50: 50); Used inorganic material is that (nano-HA, elongated piece are grown 100~150nm to nanometer hydroxyapatite, and be wide by 20~50nm); Solvent for use is dichloromethane (CH 2Cl 2); Used porogen is sodium chloride (NaCl, particle diameter 200~300 μ m).The stack trays thickness of desire preparation is 3mm, and each layer thickness is 1mm.The ground floor of support (bottom) composition is nano-HA and PLGA mixture, and the mass ratio of nano-HA and PLGA is 40: 60; The second layer of support (intermediate layer) composition is nano-HA and PLGA mixture, and the mass ratio of nano-HA and PLGA is 20: 80; The 3rd layer of (top layer) composition of support is pure PLGA.Preparation is during support, begins preparation from the 3rd layer of support, and until ground floor, promptly mold bottom is the top layer of support in preparation process, is the intermediate layer on it, and last is the bottom of support.
Take by weighing 0.2g PLGA, be dissolved in 1.2ml CH 2Cl 2In, treat that PLGA dissolves the back fully and adds 1.8g NaCl, stir and form uniform sizing material, slurry is poured in the mould, and made slurry evenly be laid on mold bottom, left standstill 2 hours, treat solvent evaporates, form the 3rd layer of support.
Take by weighing 0.16g PLGA, be dissolved in 1.2ml CH 2Cl 2In, treat that PLGA dissolves the back fully and adds 0.04g nano-HA, stir and form uniform sizing material, add 1.8g NaCl again, stir to form uniform sizing material, slurry is poured in the mould, and slurry evenly is laid on the 3rd layer on the support of shaping, left standstill 2 hours, and treated solvent evaporates, form the second layer of support.
Take by weighing 0.12g PLGA, be dissolved in 1.2ml CH 2Cl 2In, treat that PLGA dissolves the back fully and adds 0.08g nano-HA, stir and form uniform sizing material, add 1.8g NaCl again, stir and form uniform sizing material, slurry is poured in the mould, and slurry evenly is laid on the support second layer of shaping, left standstill 2 hours, and treated solvent evaporates, form the ground floor of support.
Article shaped is placed fume hood, 30 ℃ of volatilization demouldings after 48 hours down.Article shaped is immersed in the deionized water, changed a deionized water, and in the water that soaks usefulness, can not detect chloride ion (Cl in per 4 hours -).With article shaped lyophilization 36 hours, make the porous lamination compound rest again.
After testing, this support average thickness is 3.05 millimeters, and porosity is 91.4%, adheres to specification.Experiment showed, that through external and vivo degradation this scaffold degradation product is nontoxic, can not cause aseptic inflammation, support degradation time in vivo is 28 days, meets the requirement of clinical ossa articularia repair of cartilage.Repair through animal and experiment showed, that this support can repair the ossa articularia cartilage defect of dark and subchondral bone well.
Embodiment 3
Preparation thickness is hydroxyapatite/polylactic acid-hydroxyacetic acid/four layers of compound rest of polycaprolactone of 4.5 millimeters.Mould therefor is that an internal diameter is the cylindrical flat glass container of 40mm.50) and polycaprolactone (PCL, molecular weight 70000) used organic material is polylactic-co-glycolic acid (PLGA, molecular weight 100000, LA: GA=50:; Used inorganic material is that (nano-HA, elongated piece are grown 100~150nm to nanometer hydroxyapatite, and be wide by 20~50nm); Solvent for use is chloroform (chloroform, CHCl 3) and oxolane (tetrahydrofuran, THF); Used porogen is sodium chloride (NaCl is divided into particle diameter and is two kinds of 50~200 μ m and 200~300 μ m).The stack trays thickness of desire preparation is 4.5mm, and the ground floor of its medium-height trestle (bottom) thickness is 1mm, and composition is the mixture of nano-HA and PCL, and the mass ratio of nano-HA and PCL is 40: 60; Second layer thickness is 1mm, and composition is the mixture of nano-HA and PCL, and the mass ratio of nano-HA and PCL is 30: 70; The threeply degree is 0.5mm, and composition is the mixture of nano-HA and PLGA, and the mass ratio of nano-HA and PLGA is 20: 80; The 4th layer of (top layer) thickness is 2mm, and composition is pure PLGA.Preparation is during support, begins preparation from the ground floor of support, and until the 4th layer, promptly mold bottom is the bottom of support in preparation process, and last is the top layer of support.
Take by weighing 0.12g PCL, be dissolved among the 1.2ml THF, treat that PCL dissolves the back fully and adds 0.08g nano-HA, stir and form uniform sizing material, add 1.8g NaCl again, stir and form uniform sizing material, slurry is poured in the mould, and made slurry evenly be laid on mold bottom, put into 90 ℃ of baking ovens and left standstill 6 hours, treat solvent evaporates, form the ground floor of support.
Take by weighing 0.14g PCL, be dissolved among the 1.2ml THF, treat that PCL dissolves the back fully and adds 0.06g nano-HA, stir and form uniform sizing material, add 1.8g NaCl again, stir and form uniform sizing material, slurry is poured in the mould, and slurry evenly is laid on the 3rd layer on the support of shaping, put into 90 ℃ of baking ovens and left standstill 6 hours, treat solvent evaporates, form the second layer of support.
Take by weighing 0.08g PLGA, be dissolved in 0.6ml CHCl 3In, treat that PLGA dissolves the back fully and adds 0.02g nano-HA, stir and form uniform sizing material, add 0.9g NaCl again, stir to form uniform sizing material, slurry is poured in the mould, and slurry evenly is laid on the 4th layer on the support of shaping, left standstill 2 hours, and treated solvent evaporates, form the 3rd layer of support.
Take by weighing 0.4g PLGA, be dissolved in 2.5ml CHCl 3In, treat that PLGA dissolves the back fully and adds 1.5g NaCl, stir and form uniform sizing material, slurry is poured in the mould, and slurry evenly is laid on the 3rd layer on the support of shaping, left standstill 6 hours, treat solvent evaporates, form the 4th layer of support.
Article shaped is placed fume hood, 30 ℃ of volatilization demouldings after 48 hours down.Article shaped is immersed in the deionized water, changed a deionized water, and in the water that soaks usefulness, can not detect chloride ion (Cl in per 6 hours -).With article shaped lyophilization 48 hours, make the porous lamination compound rest again.
After testing, this support average thickness is 4.50 millimeters, and porosity is 88.6%, adheres to specification.Experiment showed, that through external and vivo degradation this scaffold degradation product is nontoxic, can not cause aseptic inflammation, support degradation time in vivo is 40 days, meets the requirement of clinical bone repair of cartilage.Repair through animal and experiment showed, that this support can repair the ossa articularia cartilage defect of dark and osseous tissue well.
It should be noted last that, above embodiment is only unrestricted in order to technical scheme of the present invention to be described, although the present invention is had been described in detail with reference to preferred embodiment, those of ordinary skill in the art is to be understood that, can make amendment or be equal to replacement technical scheme of the present invention, and not breaking away from the spirit and scope of technical solution of the present invention, it all should be encompassed in the middle of the claim scope of the present invention.

Claims (13)

1.一种超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,该制备方法包括以下步骤:1. A preparation method of an ultrathin porous laminated gradient tissue engineering composite support, characterized in that the preparation method may further comprise the steps: 1)根据修复缺损情况,确定待制备支架的材料和结构;1) Determine the material and structure of the stent to be prepared according to the condition of the repair defect; 2)将制备第一层支架的有机材料溶于溶剂中,所用溶剂为易挥发溶剂,待有机材料完全溶解后,再加入无机材料,搅拌形成均匀的混合浆料,再将此混合浆料倒在一个平底模具中,使浆料均匀平铺于模具底部,然后置于有利于溶剂挥发的环境中,等待溶剂挥发,挥发时间为0.5~12小时,混合浆料逐渐变干成型;2) Dissolving the organic material for preparing the first layer of stent in a solvent, the solvent used is a volatile solvent, after the organic material is completely dissolved, then adding the inorganic material, stirring to form a uniform mixed slurry, and then pouring the mixed slurry In a flat-bottomed mold, spread the slurry evenly on the bottom of the mold, then place it in an environment conducive to solvent volatilization, and wait for the solvent to volatilize. The volatilization time is 0.5 to 12 hours, and the mixed slurry gradually dries and forms; 3)按照步骤2)的操作,制备第二层支架的混合浆料,将混合浆料直接倒在已制备成型的第一层支架上,并使浆料平铺均匀,然后置于有利于溶剂挥发的环境中,等待溶剂挥发,浆料逐渐变干成型;3) According to the operation of step 2), prepare the mixed slurry of the second layer of support, pour the mixed slurry directly on the prepared first layer of support, and spread the slurry evenly, and then place it in a favorable solvent In a volatile environment, wait for the solvent to evaporate, and the slurry will gradually dry and form; 4)按照步骤3)的操作,逐层制备第三至第N层支架(N≥2);4) According to the operation of step 3), the third to Nth layers of scaffolds (N≥2) are prepared layer by layer; 5)将成型物置于通风处,等待残留溶剂完全挥发后脱模;5) Place the molding in a ventilated place, and wait for the residual solvent to evaporate completely before demoulding; 6)取出成型物,进行干燥,即得超薄多孔叠层梯度组织工程复合支架。6) Take out the molded product and dry it to obtain an ultra-thin porous laminated gradient tissue engineering composite scaffold. 2.根据权利要求1所述的超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,所述步骤2)至步骤4)中可加入致孔剂,其具体步骤为:将致孔剂与无机材料混合均匀,再加入有机材料的溶液中,搅拌形成均匀的混合浆料。2. The preparation method of the ultra-thin porous laminated gradient tissue engineering composite scaffold according to claim 1, wherein a porogen can be added in the step 2) to step 4), and the specific steps are: The porogen is mixed evenly with the inorganic material, then added into the solution of the organic material, and stirred to form a uniform mixed slurry. 3.根据权利要求2所述的超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,所述加入致孔剂的具体步骤为:将无机材料加入有机材料的溶液并搅拌均匀之后,再加入致孔剂,搅拌形成均匀的混合浆料。3. The preparation method of the ultra-thin porous laminated gradient tissue engineering composite scaffold according to claim 2, wherein the specific step of adding the porogen is: adding the inorganic material to the solution of the organic material and stirring evenly , then add the porogen, and stir to form a uniform mixed slurry. 4.根据权利要求1所述的超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,所述步骤2)至步骤4)中加入致孔剂后,步骤5)中的成型物需要用纯水进行浸泡,除去致孔剂。4. The preparation method of the ultra-thin porous laminated gradient tissue engineering composite scaffold according to claim 1, characterized in that, after the porogen is added in the step 2) to the step 4), the molding in the step 5) It needs to be soaked in pure water to remove the porogen. 5.根据权利要求1所述的超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,所述某一层的制备过程中,所用溶剂的量能够完全溶解制备该层所用的有机材料,且制备该层所用的无机材料不溶于该溶剂,但无机材料必须均匀分散于混合流动相中。5. the preparation method of ultra-thin porous laminated gradient tissue engineering composite support according to claim 1, is characterized in that, in the preparation process of described certain layer, the amount of solvent used can dissolve completely and prepare the used organic compound of this layer. Materials, and the inorganic materials used to prepare the layer are insoluble in the solvent, but the inorganic materials must be uniformly dispersed in the mixed mobile phase. 6.根据权利要求1所述的超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,所述无机材料占各层支架的质量百分比为0%~60%。6. The preparation method of the ultra-thin porous laminated gradient tissue engineering composite scaffold according to claim 1, characterized in that the mass percentage of the inorganic material in each layer of the scaffold is 0%-60%. 7.根据权利要求1、2、3或5任意一项所述的超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,所述有机材料为人工合成聚合物材料或天然聚合物材料,或者是工合成聚合物材料和天然聚合物材料的混合。7. according to the preparation method of the ultra-thin porous laminated gradient tissue engineering composite scaffold described in any one of claim 1, 2, 3 or 5, it is characterized in that, described organic material is synthetic polymer material or natural polymer materials, or a mixture of synthetic polymer materials and natural polymer materials. 8.根据权利要求7所述的超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,所述人工合成聚合物材料为聚乳酸(聚丙交酯,polylactic acid,PLA)、聚羟基乙酸(聚乙交酯、聚乙醇酸,polyglycolic acid,PGA)、聚乳酸-羟基乙酸共聚物(poly(lactic-co-glycolic acid),PLGA)、聚己内酯(polycaprolactone,PCL)、聚酰胺(polyamide,PA)、聚乙烯醇(polyvinyl alcohol,PVA)。8. the preparation method of ultra-thin porous laminated gradient tissue engineering composite support according to claim 7, is characterized in that, described synthetic polymer material is polylactic acid (polylactide, polylactic acid, PLA), polyhydroxy Acetic acid (polyglycolide, polyglycolic acid, polyglycolic acid, PGA), poly(lactic-co-glycolic acid), poly(lactic-co-glycolic acid), PLGA), polycaprolactone (polycaprolactone, PCL), polyamide (polyamide, PA), polyvinyl alcohol (polyvinyl alcohol, PVA). 9.根据权利要求7所述的超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,所述天然聚合物材料为丝素蛋白(fibroin)、胶原(collagen)、壳聚糖(chitosan)、透明质酸(haluronic acid,HA)。9. the preparation method of ultra-thin porous laminated gradient tissue engineering composite support according to claim 7, is characterized in that, described natural polymer material is silk fibroin (fibroin), collagen (collagen), chitosan ( chitosan), hyaluronic acid (haluronic acid, HA). 10.根据权利要求1、2、3、5或6任意一项所述的超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,所述无机材料为钙磷系列活性生物材料。10. The preparation method of the ultra-thin porous laminated gradient tissue engineering composite scaffold according to any one of claims 1, 2, 3, 5 or 6, wherein the inorganic material is a calcium-phosphorus series active biological material. 11.根据权利要求10所述的超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,所述钙磷系列活性生物材料为羟基磷灰石(hydroxyapatite,HA)、α磷酸三钙(α-tricalcium phosphate,α-TCP)、β磷酸三钙(β-tricalciumphosphate,β-TCP)、磷酸四钙以及元素掺杂改性钙磷生物材料。11. The preparation method of the ultra-thin porous laminated gradient tissue engineering composite scaffold according to claim 10, wherein the calcium-phosphorus series active biomaterials are hydroxyapatite (hydroxyapatite, HA), alpha tricalcium phosphate (α-tricalcium phosphate, α-TCP), β-tricalcium phosphate (β-tricalcium phosphate, β-TCP), tetracalcium phosphate and element-doped modified calcium phosphorus biomaterials. 12.根据权利要求2至4任意一项所述的超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,所述致孔剂为固体颗粒,粒径为30~500微米,所使用的致孔剂不溶于制备该层时使用的溶剂,但溶于水。12. The preparation method of the ultra-thin porous laminated gradient tissue engineering composite scaffold according to any one of claims 2 to 4, wherein the porogen is a solid particle with a particle size of 30 to 500 microns, and the The porogen used is insoluble in the solvent used to prepare the layer, but soluble in water. 13.根据权利要求4所述的超薄多孔叠层梯度组织工程复合支架的制备方法,其特征在于,所述纯水为蒸馏水、去离子水或反渗透水。13. The preparation method of the ultra-thin porous laminated gradient tissue engineering composite scaffold according to claim 4, wherein the pure water is distilled water, deionized water or reverse osmosis water.
CN200910306024A 2009-08-25 2009-08-25 Method for preparing ultra-thin porous lamination gradient composite support of tissue engineering Pending CN101628131A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910306024A CN101628131A (en) 2009-08-25 2009-08-25 Method for preparing ultra-thin porous lamination gradient composite support of tissue engineering

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910306024A CN101628131A (en) 2009-08-25 2009-08-25 Method for preparing ultra-thin porous lamination gradient composite support of tissue engineering

Publications (1)

Publication Number Publication Date
CN101628131A true CN101628131A (en) 2010-01-20

Family

ID=41573519

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910306024A Pending CN101628131A (en) 2009-08-25 2009-08-25 Method for preparing ultra-thin porous lamination gradient composite support of tissue engineering

Country Status (1)

Country Link
CN (1) CN101628131A (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102973984A (en) * 2012-12-25 2013-03-20 成都维德医疗器械有限责任公司 Preparation method and application of composite porous scaffold
CN103656745A (en) * 2013-12-12 2014-03-26 天津大学 Gel-poly(lactide-co-glycolide) (PLGA) two-phase gradient transition cartilage-bone repair material and preparation thereof
CN103721293A (en) * 2013-07-25 2014-04-16 天津大学 Photo-crosslinking multilayer gradient hydrogel capable of controllably releasing active factors and preparation method of hydrogel
CN103893818A (en) * 2014-03-14 2014-07-02 华南理工大学 Osteochondral three-dimensional stent with regular interpenetrating network structure and preparation method thereof
CN105412974A (en) * 2015-11-27 2016-03-23 广州市朴道联信生物科技有限公司 Preparation method of cornea repair material of double-layer structure
CN106139255A (en) * 2015-04-17 2016-11-23 天津市赛宁生物工程技术有限公司 A kind of collagen protein combines new material and the preparation method of the medical sponge support of calcium phosphate
CN106178126A (en) * 2016-07-16 2016-12-07 遵义市第人民医院 A kind of reparation bone cartilage two-phase porous compound support frame and preparation method thereof
CN106999633A (en) * 2014-09-29 2017-08-01 克莱蒙奥弗涅大学 The transformable hybrid material implant of porosity
CN107137770A (en) * 2017-04-25 2017-09-08 昆明理工大学 A kind of composite multi-layer porous support and preparation method thereof
CN108404208A (en) * 2018-05-25 2018-08-17 姜香 A kind of preparation method of wear-resistant type artificial joint material
CN108498866A (en) * 2018-04-26 2018-09-07 海南科技职业学院 A kind of compound polycaprolactone of modified hydroxylapatite-chitosan duplicature and preparation method thereof
CN108578777A (en) * 2018-05-06 2018-09-28 西北工业大学 A kind of artificial os osseum holder preparation method that growth factor concentration gradient is controllable
CN109172044A (en) * 2018-07-24 2019-01-11 西安交通大学 A kind of degradable gradient-porosity mammary gland bracket
CN109251493A (en) * 2018-07-31 2019-01-22 哈工大(威海)创新创业园有限责任公司 A kind of compound bio biocompatible porous film and preparation method thereof
CN110124101A (en) * 2019-06-19 2019-08-16 成都理工大学 A kind of compound porous bone tissue engineering stent material of calcium citrate/polylactic acid and preparation method thereof
CN110170074A (en) * 2019-06-19 2019-08-27 成都理工大学 A kind of calcium citrate/polylactic acid bone renovating material of melt-blending process preparation and its application
CN110201238A (en) * 2019-06-19 2019-09-06 成都理工大学 A kind of calcium citrate/polycaprolactone/polylactic acid bone renovating material and its application
CN110201239A (en) * 2019-06-19 2019-09-06 成都理工大学 A kind of calcium citrate/polycaprolactone composite bone repairing material and its application
CN110944685A (en) * 2017-05-10 2020-03-31 阿肯色大学理事会 Biocompatible structures for tissue regeneration and methods of making and using the same
CN111346260A (en) * 2020-03-11 2020-06-30 四川大学 Mechanically adaptable bioactive ceramic armor and preparation method thereof
CN115970061A (en) * 2023-01-31 2023-04-18 上海卓阮医疗科技有限公司 Biomaterial for lack of blood supply scene and its preparation method and application

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102973984A (en) * 2012-12-25 2013-03-20 成都维德医疗器械有限责任公司 Preparation method and application of composite porous scaffold
CN102973984B (en) * 2012-12-25 2015-05-13 成都维德医疗器械有限责任公司 Preparation method and application of composite porous scaffold
CN103721293A (en) * 2013-07-25 2014-04-16 天津大学 Photo-crosslinking multilayer gradient hydrogel capable of controllably releasing active factors and preparation method of hydrogel
CN103656745A (en) * 2013-12-12 2014-03-26 天津大学 Gel-poly(lactide-co-glycolide) (PLGA) two-phase gradient transition cartilage-bone repair material and preparation thereof
CN103656745B (en) * 2013-12-12 2015-02-18 天津大学 Gel-poly(lactide-co-glycolide) (PLGA) two-phase gradient transition cartilage-bone repair material and preparation thereof
CN103893818A (en) * 2014-03-14 2014-07-02 华南理工大学 Osteochondral three-dimensional stent with regular interpenetrating network structure and preparation method thereof
CN106999633A (en) * 2014-09-29 2017-08-01 克莱蒙奥弗涅大学 The transformable hybrid material implant of porosity
CN106139255A (en) * 2015-04-17 2016-11-23 天津市赛宁生物工程技术有限公司 A kind of collagen protein combines new material and the preparation method of the medical sponge support of calcium phosphate
CN105412974A (en) * 2015-11-27 2016-03-23 广州市朴道联信生物科技有限公司 Preparation method of cornea repair material of double-layer structure
CN106178126A (en) * 2016-07-16 2016-12-07 遵义市第人民医院 A kind of reparation bone cartilage two-phase porous compound support frame and preparation method thereof
CN107137770A (en) * 2017-04-25 2017-09-08 昆明理工大学 A kind of composite multi-layer porous support and preparation method thereof
CN110944685A (en) * 2017-05-10 2020-03-31 阿肯色大学理事会 Biocompatible structures for tissue regeneration and methods of making and using the same
CN108498866A (en) * 2018-04-26 2018-09-07 海南科技职业学院 A kind of compound polycaprolactone of modified hydroxylapatite-chitosan duplicature and preparation method thereof
CN108578777A (en) * 2018-05-06 2018-09-28 西北工业大学 A kind of artificial os osseum holder preparation method that growth factor concentration gradient is controllable
CN108578777B (en) * 2018-05-06 2021-05-07 西北工业大学 A kind of artificial hard bone scaffold preparation method with controllable growth factor concentration gradient
CN108404208A (en) * 2018-05-25 2018-08-17 姜香 A kind of preparation method of wear-resistant type artificial joint material
CN109172044A (en) * 2018-07-24 2019-01-11 西安交通大学 A kind of degradable gradient-porosity mammary gland bracket
CN109251493A (en) * 2018-07-31 2019-01-22 哈工大(威海)创新创业园有限责任公司 A kind of compound bio biocompatible porous film and preparation method thereof
CN109251493B (en) * 2018-07-31 2020-11-24 哈工大(威海)创新创业园有限责任公司 A kind of composite biocompatible porous membrane and preparation method thereof
CN110124101A (en) * 2019-06-19 2019-08-16 成都理工大学 A kind of compound porous bone tissue engineering stent material of calcium citrate/polylactic acid and preparation method thereof
CN110201239A (en) * 2019-06-19 2019-09-06 成都理工大学 A kind of calcium citrate/polycaprolactone composite bone repairing material and its application
CN110201238A (en) * 2019-06-19 2019-09-06 成都理工大学 A kind of calcium citrate/polycaprolactone/polylactic acid bone renovating material and its application
CN110170074A (en) * 2019-06-19 2019-08-27 成都理工大学 A kind of calcium citrate/polylactic acid bone renovating material of melt-blending process preparation and its application
CN111346260A (en) * 2020-03-11 2020-06-30 四川大学 Mechanically adaptable bioactive ceramic armor and preparation method thereof
CN111346260B (en) * 2020-03-11 2021-09-14 四川大学 Mechanical adaptive bioactive ceramic armor and preparation method thereof
CN115970061A (en) * 2023-01-31 2023-04-18 上海卓阮医疗科技有限公司 Biomaterial for lack of blood supply scene and its preparation method and application

Similar Documents

Publication Publication Date Title
CN101628131A (en) Method for preparing ultra-thin porous lamination gradient composite support of tissue engineering
Zhu et al. Effect of the nano/microscale structure of biomaterial scaffolds on bone regeneration
Yin et al. Recent advances in scaffold design and material for vascularized tissue‐engineered bone regeneration
Du et al. 3D printing of mesoporous bioactive glass/silk fibroin composite scaffolds for bone tissue engineering
Pina et al. Natural‐based nanocomposites for bone tissue engineering and regenerative medicine: A review
Yang et al. 3D-printed bioactive Ca3SiO5 bone cement scaffolds with nano surface structure for bone regeneration
Wang et al. Injectable, high specific surface area cryogel microscaffolds integrated with osteoinductive bioceramic fibers for enhanced bone regeneration
Chim et al. A comparative analysis of scaffold material modifications for load-bearing applications in bone tissue engineering
Yeo et al. Three-dimensional hierarchical composite scaffolds consisting of polycaprolactone, β-tricalcium phosphate, and collagen nanofibers: fabrication, physical properties, and in vitro cell activity for bone tissue regeneration
Liu et al. Delivery of growth factors using a smart porous nanocomposite scaffold to repair a mandibular bone defect
Kim et al. PCL/alginate composite scaffolds for hard tissue engineering: Fabrication, characterization, and cellular activities
Liu et al. Design and development of three-dimensional scaffolds for tissue engineering
CN100546661C (en) Preparation method of in situ pore-forming self-curing calcium phosphate composite tissue engineering scaffold
Shi et al. β-TCP scaffold coated with PCL as biodegradable materials for dental applications
Manoukian et al. Spiral layer-by-layer micro-nanostructured scaffolds for bone tissue engineering
Cui et al. A novel nano/micro-fibrous scaffold by melt-spinning method for bone tissue engineering
CN109453426A (en) A kind of Bone Defect Repari bioactive ceramics fibrous composite scaffold and preparation method thereof
Xie et al. A novel bioceramic scaffold integrating silk fibroin in calcium polyphosphate for bone tissue-engineering
Bu et al. In situ precipitation of cluster and acicular hydroxyapatite onto porous poly (γ-benzyl-l-glutamate) microcarriers for bone tissue engineering
Arahira et al. Development and characterization of a novel porous β-TCP scaffold with a three-dimensional PLLA network structure for use in bone tissue engineering
Cao et al. Development of degradable and bioactive composite as bone implants by incorporation of mesoporous bioglass into poly (L-lactide)
Sun et al. 3D-printed, bi-layer, biomimetic artificial periosteum for boosting bone regeneration
He et al. Novel extrusion-microdrilling approach to fabricate calcium phosphate-based bioceramic scaffolds enabling fast bone regeneration
Remy et al. Rat calvarial bone regeneration by 3D-printed β-tricalcium phosphate incorporating microRNA-200c
Xia et al. The effect of pore size on cell behavior in mesoporous bioglass scaffolds for bone regeneration

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100120